Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
87p to buy even poxy stake lol
VERY interesting post today by Feedbacks MD in India Rohit Singh. This is what he says….
‘ It's always my pleasure meeting you Dr Sanjay Durani, Medical Superintendent at Sanar International Hospitals, now part of Shalby Limited. Your dedication to excellence in healthcare is both admirable and inspiring. Learning about the unwavering commitment of your hospital to deliver exceptional healthcare services and prioritize patient experiences as the cornerstone of its mission is truly uplifting.’
OK so Sanjay Durani is the Medical Superintendent at Sanar International Hospitals. The MS in India is the person who is in charge of and runs the enterprise. You could say the guy who makes decisions about organisational strategy and working procedures amongst other things. The only role above him is the MD. Sanar international hospitals is owned by Shelby Limited.
https://www.shalby.org/about-us/about-shalby/
On their website Shalby talk about ‘patient-centric’ care. Now where have I heard that phrase used before? ;)
Now Rohit is showering praise on this guy in the LinkedIn post but I’m sure his visit was more than just about mutual pleasantries with a cup of tea don’t you think? ;)
Rohit has a mighty big smile on his face too. I wonder why? ;)
Anyone else think they were striking a Bleepa deal?
Up 35% since I bought the bottom
however still a long way to go.
...
After shares (still) offering 82p for upto 10k now. They're gonna have to let it go eventually.
And you couldn't even buy a poxy 3000@82p earlier
(the 78.xxp tiddly trades were sells)
Ian,
The sell price has been held at 66 for some days the buy price was 72 then rising to 74 then it pinged at the end.
The reason is now understood.
7.86% increase on one refresh of the screen, I call that a big jump, you are obviously a high flyer Ian and used to much larger extremes.
I concur I_B. You’d think they’d be encouraging buyers to fill what was clearly a sell order. So, as you say, there is always someone on the other side of a transaction. Maybe Mr Cranston or someone else building their stake. Clearly that stock was snapped up, we know that much.
Strange that they weren't letting buyers in while trying to fill that one. Maybe another trade will pop up to explain it but given the price action it doesn't make much sense?
How the hell is 7.86% a big jump!!!!
Late rise AND that 1 trade, surely a 7am rns is nailed on!... I jest, but I will be tuning in tomorrow AM just in case!
I would love to believe this late rise is the indicator of imminent positive news. However it’s more likely that it’s simply that MM’s have no stock and just hiked the bid late on to try and drum up some business.
Big jump at the end, what they landed?
Just got a dummy quote for 20k before the end of play and they were offering 75! 75.50 for 10. Something definitely brewing!
Nice steady rise here
couldn't believe I got these at the bottom
"Feedback Medical is also involved in supporting and delivering 40 community diagnostic centres (CDCs) across England."
More details here.
https://studiomade.co/work/bleepa/
And we also know that in terms of ARR (because the NHS,once you land them,is a long term partner) the total addressable market for CDC’s alone (not including the rest of the NHS) is £96m pa.
It therefore follows that if FDBK were to land even a fraction of that number this will multibag from here.
QVH has been recognised nationally for this innovative work on the ‘breathlessness pathway’. This work has been presented nationally and regionally at the request of Sir Mike Richards and the NHS England CDC development team.
And we all know Bleepa powers the breathlessness pathway..
I can now dummy sell large volume of stock @ 72p. A clear two pence above the current mid price. Bizarre how the bid hasn’t moved. It must be one stubborn MM stuck on 66.
Continued.....
Moving forward into 2023/24
• QVH is also involved in national pilot work on the skin pathway, sharing best practice and learning with other CDCs.
• From April 2023 the abdominal pathway will provide differential diagnosis around another common set of symptoms.
• Expansion and further development of patient clinical pathways including chronic cough and headache.
• Electronic key performance indicator monitoring through the digital platform, this will enable performance to be monitored closely, ensuring the best outcome for patients.
• Improve wider pathways and access to management and onward referral for patients without having to go back through primary care for this referral process.
• From April 2023 tests available for GPs to order will also include 24 hour blood pressure and 24 hour ECG monitoring
• The number of GP practices which QVH works with will be increased.
• Over the next two years QVH will receive national investment to support both workforce and treatment space. There are national workforce challenges in regarding to imaging and diagnostic expertise, so QVH workforce plans include apprenticeships and other routes to developing skilled staff. There will be a phased recruitment approach to meet the anticipated growth in demand as the service is extended to cover more GP surgery catchments and additional tests.
• The CDC currently operates out of pre-existing QVH clinical space but plans are developing for a new dedicated building
Very interesting reading, Bleepa an integral part of the QVH digital Pathways. Page 40/41
https://www.qvh.nhs.uk/wp-content/uploads/2023/06/QVH-Quality-Report-2022-3.pdf
NHS Community diagnostic centres (CDCs) provide a broad range of elective diagnostics (including checks, scans and tests) away from acute facilities, so reducing pressure on hospitals, providing quicker access to tests and greater convenience to patients. The improved access provided by the CDCs supports reducing unwarranted variation in referral,
access and associated health inequalities. The QVH CDC was established to start delivering digitally connected diagnostic capacity for the local population. The service provides, in as few visits as possible, coordinated diagnostic tests enabling fast diagnosis on a range of a clinical pathways to improve experience and outcomes.
A working group of clinicians co-chaired by the National Clinical Directors for Respiratory and Heart Disease and finalised in November 2021 developed a breathlessness pre-diagnosis pathway. The pathway was developed in response to the common presentation of breathlessness in primary care and associated delays in treatment and avoidable hospital
admissions. The pathway includes an asynchronous multidisciplinary (MDT) approach to support the clinical decision making and patient treatment.
The team at Queen Victoria Hospital Community Diagnostic Centre have been piloting the pathway through the CDC outpatient setting, with the aim of delivering on the objectives of increasing diagnostic capacity, improving productivity and efficiency, delivering a more personalised diagnostic experience, supporting integration of care, improving staff
development and satisfaction and making every contact count. The aim of the pathway is not to monitor known diagnoses that have deteriorated but to focus on speeding up new diagnoses.
QVH has been recognised nationally for this innovative work on the ‘breathlessness pathway’. This work has been presented nationally and regionally at the request of Sir Mike Richards and the NHS England CDC development team
QVH is currently working with eight local General Practitioner (GP) practices. GPs in these practices are able to refer their patients for breathlessness pathway and physiological tests including spirometry, FeNO (measuring exhaled nitrous oxide, a biomarker for asthma) and electrocardiogram (ECG).
Still nothing available and after that little sell they're offering 71.77 on big volume. Expecting a sizeable buy to pop up at some point & it could move sharply from here.
Apparently schools already have a simplified system that teachers can use, it prolly doesn't have my useful note system about James though.
Coffee - education yes…… there’s a few here that could do with some education lol. Let’s not forget the military either. Tom mentioned, in an answer in the webcast, that the military could be an ideal fit.
Https://www.globenewswire.com/news-release/2022/02/18/2387792/28124/en/India-Healthcare-Apps-Market-Report-2021-Market-was-Valued-at-INR-43-41-Bn-in-2020-and-is-Estimated-to-Reach-INR-337-89-Bn-by-2026-Growing-at-a-CAGR-of-39-37.html
Healthcare Apps market in India to grow by almost 40% CAGR. Digitalisation of the healthcare industry in India is taking off. Feedback, right place right time. Two Healthcare Innovation Awards in past week.
Feedback guy in charge in India was key player in UK India Business Council for years with high reputation and big network of connections in the country.
We do not have to pin all our hopes on the NHS (thank goodness). Join the dots peeps.
Dear Tom,
Another instance this would work is education.
Kids with special educational needs are often missed as each teacher doesn't know their rse from their elbow, most ppl only have a handful of decent teachers throughout their 5 - 7 years of schooling, the rest of them flounder or dodge their way through ( similar to NHS id guess ) .
Bang each child onto Bleepa, central school hub controls the data, each teacher can anote and update if child X gets a laptop, extra exam time, is allowed to go to a quiet room, detentions, after schools, weekends etc.
Again, sell it into the private sector first ( they pay for excellence ) let it slowly roll downhill until someone ( politician at election time ) propels it into the state system.
Teachers have mobiles phones, what they don't remember are the hundreds of emails from other staff saying, 'to remind all staff, little Johnny is allergic to X , Fred can have a quiet time out of the classroom if he is feeling sensory overload, and James is just a little 6unt there's nothing actually wrong with him.